SPHK2 and Alzheimer disease: Full length SphK2 expression was increased in the nuclei enriched fraction (F(1,28) = 3.9; p = 0.050) but was decreased in cytoplasmic enriched fraction (F(1,28) = 5.4; p = 0.027) in AD group relative to the control (Fig. 4b).